Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Halon, a leading email infrastructure software provider, on its sale to Intera Partners Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on Egetis Therapeutics’ SEK 300 million Follow-On Offering Bryan, Garnier & Co acts as Sole Financial Advisor to Groupe Technic Assistance on the contemplated sale of the Company to NEO2, supported by CAPZA and Turenne Groupe Bryan, Garnier & Co acts as Sole Financial Advisor to NetGuardians and its shareholders on the investment from Summa Equity Bryan, Garnier & Co acts as Sole Financial Advisor to Isoskèle, subsidiary of La Poste Groupe, on the contemplated acquisition of LineUP7, a leading data marketing agency Bryan, Garnier & Co acts as Sole Financial Advisor to Abenex and the Management of EDL on a secondary LBO led by Dentressangle Capital Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Valneva’s EUR 61.2m Follow-On Offering Bryan, Garnier & Co. acts as Sole Secondary Advisor to a group of historical shareholders in Algolia on the secondary sale of their shares to Noteus Partners, Karmel Capital and Revaia Bryan, Garnier & Co acts as Sole Financial Advisor to CENIT on their majority acquisition of Analysis Prime Bryan, Garnier & Co acts as Sole Financial Advisor to Francisco Partners on its investment in Orisha, a leading European Vertical Market Software platform Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Nicox’s Euronext Paris EUR 3.3m Rights Issue Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Cinclus Pharma’s SEK 715m Nasdaq Stockholm IPO
